SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
SCHEDULE 13G
Amendment 5
Under the Securities and Exchange Act of 1934
Diagnostic Products Corp.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
--------------------------------------------------------------------------------
(Title of Class of Securities)
252450101
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2006
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
This Schedule is filed pursuant to Rule 13d-1(b)
The information required in the remainder of this cover page (except any items
to which the form provides a cross-reference) shall not be deemed to be
"filed" for the purpose of Section 18 of the Securities Exchange Act of 1934
("Act") or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act.
CUSIP NO. 252450101
----------
1) Name of Reporting Person Ameriprise Financial, Inc.
S.S. or I.R.S. Identification IRS No. 13-3180631
No. of Above Person
--------------------------------------------------------------------------------
2) Check the Appropriate Box (a)
---------------
if a Member of a Group (b) X*
------
*This filing describes the reporting person's relationship with other persons,
but the reporting person does not affirm the existence of a group.
--------------------------------------------------------------------------------
3) SEC Use Only
--------------------------------------------------------------------------------
4) Citizenship or Place of Organization Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING
PERSON WITH
(5) Sole Voting Power -0-
--------------------- -----------------
(6) Shared Voting Power -0-
----------------------- -----------------
(7) Sole Dispositive Power -0-
-------------------------- -----------------
(8) Shared Dispositive Power -0-
---------------------------- -----------------
--------------------------------------------------------------------------------
9) Aggregate Amount Beneficially
Owned by Each Reporting Person 0
--------------------------------------------------------------------------------
10) Check if the Aggregate Amount in
Row (9) Excludes Certain Shares Not Applicable
--------------------------------------------------------------------------------
11) Percent of Class Represented by
Amount In Row (9) 0.0%
--------------------------------------------------------------------------------
12) Type of Reporting Person CO
--------------------------------------------------------------------------------
1(a) Name of Issuer: Diagnostic Products Corp.
1(b) Address of Issuer's Principal 5700 West 96th Street
Executive Offices: Los Angeles, CA 90045
2(a) Name of Person Filing: Ameriprise Financial, Inc.
2(b) Address of Principal Business Office:
Ameriprise Financial, Inc.
145 Ameriprise Financial Center
Minneapolis, MN 55474
2(c) Citizenship: Delaware
2(d) Title of Class of Securities: Common Stock
2(e) Cusip Number: 252450101
3 Information if statement is filed pursuant to Rules 13d-1(b) or 13d-2(b):
This Statement is filed pursuant to Rule 13d-19b) or 13d-2(b) and the
person filing, Ameriprise Financial, Inc., is a parent holding company in
accordance with Rule 13d-1(b)(1)(ii)(G). (Note: See Item 7)
4(a) Amount Beneficially Owned as of December 31, 2006: Not Applicable
4(b) Percent of Class: 0.0%
4(c) Number of Shares as to which such person has:
(i) Sole power to vote or to direct the vote: 0
(ii) Shared power to vote or direct the vote: 0
(iii) Sole power to dispose or to direct the disposition of: 0
(iv) Shared power to dispose or to direct the disposition of 0
5 Ownership of 5% or Less of a Class:
If this statement is being filed to report the fact as of the date
hereof the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities, check the
following (X).
6 Ownership of more than 5% on Behalf of Another Person: Not Applicable
7 Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company:
See Exhibit I
8 Identification and Classification of Members of the Group:
Not Applicable
9 Notice of Dissolution of Group:
Not Applicable
10 Certification:
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the
effect of changing or influencing the control of the issuer of such
securities and were not acquired in connection with or as a participant in
any transaction having such purposes or effect.
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
Ameriprise Financial, Inc.
Dated: December 31, 2006 By /s/ Jeffrey P. Fox
-------------------------------
Signature
Jeffrey P. Fox
V.P. Investment Accounting
--------------------------
Name/Title
Telephone: (612) 671-6741
Exhibit Index
-------------
Exhibit I Identification and Classification of the Subsidiary
which Acquired the Security Being Reported on by the
Parent Holding Company.
Exhibit I
to
Schedule 13G
Ameriprise Financial, Inc., a Delaware Corporation, is a parent holding
company. The classification and identity of the relevant subsidiaries is as
follows:
Bank - Ameriprise Trust Company, a trust company organized under the laws of
the State of Minnesota
Investment Company - RiverSource Funds, comprised of investment companies
registered under section 8 of the Investment Company Act of 1940
Investment Adviser - RiverSource Investments, LLC, an investment adviser
registered under section 203 of the Investment Advisers Act of 1940.